top of page
gradientForSurfBreak.png

Item List

Dec 13, 2023
PR Newswire
Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions.

Recent Posts

Portfolio Company

Carlsmed.png

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Pr ...

Carlsmed

Feb 10, 2026

View More

Portfolio Company

Carlsmed.png

xCures and the Colorectal Cancer Alliance Partner to Support Patient Access and ...

The National Law Review

Feb 5, 2026

View More

Portfolio Company

Carlsmed.png

Vanguards of Health Care: Carlsmed Personalizes Spine with AI ...

Bloomberg

Feb 5, 2026

View More
surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page